Back to top

NeuroSense to file NDS to Health Canada for PrimeC for treatment of ALS

NeuroSense (NRSN) Therapeutics announced it intends to proceed with the filing of a New Drug Submission, or NDS, to Health Canada for PrimeC for th...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: